FEATURED CONTRIBUTED CONTENT

CEO Blog: Social Media Enhances My Interactions with Customers


CEO Blog: Social Media Enhances My Interactions with Customers

By Brent Saunders, CEO, Allergan As a young executive at Schering-Plough, I learned a lot from Fred Hassan about the importance of ‘Being Connected’ and ‘Tuning In’ to customers by spending time with them and our front-line sales teams. It was the best way to understand their experience with our products, identify things that we could do to improve patient […]

December 19, 2017 More Clinical »
Enhancing Therapeutic Alliance and Promoting Shared Decision Making


Enhancing Therapeutic Alliance and Promoting Shared Decision Making

The latest White Paper from the health psychology experts at Atlantis Healthcare examines how collaborative communication between healthcare professionals and their patients (the ‘therapeutic alliance’) can lead to improved patient outcomes. The paper explores the role played by pharmaceutical companies in overcoming barriers to effective patient communication during consultation and treatment. It also looks at […]

December 18, 2017 More Clinical »
The California Co-Pay Conundrum


The California Co-Pay Conundrum

TrialCard Addresses AB 265 On October 9, 2017, California Governor Jerry Brown signed AB 265 into law. This landmark piece of legislation modified the California Health and Safety Code to prohibit the “offering” of any discount, product voucher, or other out-of-pocket cost reduction tool by drug manufacturers when there is an FDA-approved therapeutic equivalent. As […]

January 2, 2018 More Clinical »
Social Media: A Rich Data Source or a Can of Worms?


Social Media: A Rich Data Source or a Can of Worms?

The rise of health-related social media (SM) has been phenomenal. It has been estimated that there are over 2.5 billion patient posts from 50 million healthcare users. Health-related SM is increasingly recognized as a potentially important source of evidence. Studies are already being undertaken that aim to directly monitor drug safety and provide evidence of […]

December 19, 2017 More Clinical »
How to avoid the 5 patient enrollment mistakes that delay clinical trials


How to avoid the 5 patient enrollment mistakes that delay clinical trials

Ever wonder why 80% of clinical trials are delayed? The top reason is unfulfilled enrollment, and there are specific reasons why this happens with so many trials This webinar will reveal 5 patient enrollment errors that stall enrollment timelines in trial after trial. More importantly, it will provide useful advice, based on proven methods, for […]

December 12, 2017 More Clinical »
2018 Healthcare Predictions


2018 Healthcare Predictions

Every year, InCrowd surveys physicians across a wide range of specialties to better understand their perspective on healthcare policies and trends, and learn what they think will happen in the year ahead. Join us as we take a look at physician predictions and insights for 2018, and how they compare to years past. In the […]

January 25, 2018 More Clinical »
Managing the Unmanageable: Meeting the Challenge of Appropriate Safety Report Distribution


Managing the Unmanageable: Meeting the Challenge of Appropriate Safety Report Distribution

As clinical trials become more complex and increasingly global, the problem of over-distributing expedited safety reports to investigative sites has reached the point that demands a solution. The excessive volume of safety reports can cause investigators to miss important reports lost in the noise of non-significant event reports, and sometimes cause them to reconsider participating […]

January 1, 2018 More Clinical »
HBAdvantage – A New Era


HBAdvantage – A New Era

A New Era. The HBA’s new brand was unveiled to a sellout crowd at its annual conference in November. With the splendor of a new style, color, flair and messaging, HBA is clearly positioned as a formidable united force for change in the healthcare industry. The new brand is a catalyst designed to accelerate HBA’s […]

January 2, 2018 More Clinical »
3 Things Health Care & Life science firms can learn from Amazon


3 Things Health Care & Life science firms can learn from Amazon

Article by Gaurav Kapoor, co founder and EVP, Indegene, a global healthcare solutions company In the recent months, there has been a lot of speculation about Amazon’s entry into the pharmaceutical sector. Given Amazon’s track record of disrupting and displacing established players in every sector they compete, it is not surprising that incumbents in the […]

January 8, 2018 More Clinical »
Access Options for Investigational Products – Key Considerations


Access Options for Investigational Products – Key Considerations

In the Fall issue of The Evidence Forum, one of the many informative articles discusses access options for investigational products, comparing and contrasting three key categories. These programs provide an important service in allowing select patient populations to receive access to experimental drugs, and as regulatory agencies place more emphasis on patient access, the need […]

December 13, 2017 More Clinical »
Improving Time-to-Market and Clinical Quality of Studies with Video EEG Protocol


Improving Time-to-Market and Clinical Quality of Studies with Video EEG Protocol

Drug development costs for Central Nervous System (CNS) trials are more complex and costly for pharmaceutical companies and often take longer to develop than other medicines. Failed studies often occur later in development when costs are the highest. For compound efficacy and safety that is being measured with electroencephalography (EEG), technical and recording difficulties simply […]

December 14, 2017 More Clinical »
Building a Collaborative HCP-Patient Relationship: Insights from Health Psychology


Building a Collaborative HCP-Patient Relationship: Insights from Health Psychology

Research shows that patients who have a good relationship with their HCPs are more likely to achieve better health outcomes and have greater adherence to their treatment. Dr. Kate Perry, Director of Behavioral Science at Atlantis Healthcare, provides insights on the benefits of a collaborative therapeutic alliance – why it’s important, how it evolves throughout […]

December 18, 2017 More Clinical »
Just-In-Time Enrollment for Oncology Trials: Get to First Patient In Faster & Mitigate Non-Enrolling Sites


Just-In-Time Enrollment for Oncology Trials: Get to First Patient In Faster & Mitigate Non-Enrolling Sites

Despite scientific advances, oncology clinical trials are still challenged by delayed trial timelines, slow site activation and poor patient enrollment. To overcome these barriers, we need to redefine the enrollment paradigm. A new trial methodology has been developed that addresses these challenges and provides sponsors with the enrollment and budget solution needed to more effectively […]

February 20, 2018 More Clinical »
FEEDBACK